TITLE

Infective Endocarditis Complicating Permanent Pacemaker and Implantable Cardioverter-Defibrillator Infection

AUTHOR(S)
Sohail, Muhammad R.; Uslan, Daniel Z.; Khan, Akbar H.; Friedman, Paul A.; Hayes, David L.; Wilson, Walter R.; Steckelberg, James M.; Jenkins, Sarah M.; Baddour, Larry M.
PUB. DATE
January 2008
SOURCE
Mayo Clinic Proceedings;Jan2008, Vol. 83 Issue 1, p46
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
OBJECTIVE: To describe management of patients with permanent pacemaker (PPM)- and implantable cardioverter-defibrillator (ICD)-related endocarditis. PATIENTS AND METHODS: We retrospectively reviewed all cases of Infection involving PPMs and ICDs among patients presenting to Mayo Clinic's site in Rochester, MN, between January 1, 1991, and December 31, 2003. Cardiac device-related infective endocarditis (CDIE) was defined as the presence of both vegetation on a device lead or valve and clinical or microbiological evidence of CDIE. Of 189 patients with PPM or lCD infection who were admitted during the study period, 44 met the case definition for CDIE (33 PPM, 11 lCD). RESULTS: The mean ± SD age of patients was 67±14 years. Staphylococci (36 [82%]) were the most commonly isolated pathogens. Nearly all patients (43 [98%]) were treated with a combined approach of complete hardware removal and parenteral antibiotics. The median duration of antibiotic treatment after infected device explantation was 28 days (interquartile range, 19- 42 days). Device leads were removed percutaneously in 34 cases (77%); only 7 cases (16%) required surgical lead extraction. Percutaneous extraction was uncomplicated in 15 patients with lead vegetation greater than 10 mm in diameter. Six patients (14%) died during hospitalization. Twenty-seven (96%) of 28 patients remained infection free at their last visit (median follow-up, 183 days; intraquartile range, 36-628 days). CONCLUSION: Prompt hardware removal and prolonged parenteral antibiotic administration decrease mortality among patients with CDIE. The presence of a large (>10 mm in diameter) vegetation on a lead is not a contraindication for percutaneous lead extraction.
ACCESSION #
28095604

 

Related Articles

  • Endocarditis at the Millennium. Hoesley, Craig J.; Cobbs, C. Glenn // Journal of Infectious Diseases;3/15/99 Supplement 2, Vol. 179, pS360 

    Focuses on the demographics, diagnostic methods and therapeutic options for the management of infective endocarditis (IE). Contributions of the members of the Interplanetary Society to the understanding of the pathogenesis of IE; Atypical pathogens causing IE; Provision of effective...

  • Intravenous Followed by Oral Antimicrobial Therapy for Staphylococcal Endocarditis. PARKER, RICHARD H.; FOSSIECK, Jr., BYRON E. // Annals of Internal Medicine;Dec80, Vol. 93 Issue 6, p832 

    We have treated 35 cases of staphylococcal endocarditis in 33 patients with intravenous followed by oral antimicrobial therapy. All patients had three or more blood cultures positive for Staphylococcus aureus, and all had cardiac murmurs characteristic of valvular insufficiency. The mean total...

  • Clinafloxacin for the Treatment of Bacterial Endocarditis. Levine, Donald P.; Holley, H. Preston; Eiseman, Irene; Willcox, Paul; Tack, Kenneth // Clinical Infectious Diseases;3/1/2004, Vol. 38 Issue 5, p620 

    We report the results of a prospective, multicenter trial assessing intravenous and oral clinafloxacin treatment for infective endocarditis. Sixty-six patients constituted the final study population. Among the 53 patients with native valve infection, Staphylococcus aureus and Streptococcus...

  • Muldoon et al (Clin Infect Dis 2013; 57:419–24).  // Clinical Infectious Diseases;Mar2014, Vol. 58 Issue 5, p754 

    A correction to the article "Are We Ready for an Outpatient Parenteral Antimicrobial Therapy Bundle? A Critical Appraisal of the Evidence" by E. G. Muldoon and colleagues that was published in the August 1, 2013 issue is presented.

  • The preparation and Evaluation of Some Metronidazole Formulations as Gels and The study of Their Medicinal Activities Against Pathogenetic Microorganisms Causing Dermatitides. Ali, Sahar A.; Al-Assady, Nadia A.; Badr, Sanaa Q.; Abu-Mejdad, Najwa M.; Al-Toma, Muselm A.; Sayyah, Sahera Ghareeb // Basrah Journal of Agricultural Sciences;Jul2014, Vol. 40 Issue 2, p33 

    In the present study, a labor has been made to develop gel type of transdermal therapeutic system comprising different concentrations of metronidazole with hydrophilic polymeric combinations using solid dispersion method. Two main parts including chemical and biochemical were discussed in this...

  • Antimicrobial Treatment of Infective Endocarditis due to Viridans Streptococci, Enterococci, and Staphylococci. Bisno, Alan L.; Dismukes, William E.; Durack, David T.; Kaplan, Edward L.; karchmer, Adolf W.; Kaye, Donald; Rahimtoola, Shahbudin H.; Sande, Merle A.; sanford, Jay P.; Watanakunakorn, Chatchai; Wilson, Walter R. // JAMA: Journal of the American Medical Association;3/10/89, Vol. 261 Issue 10, p1471 

    Reports on the antimicrobial treatment of infective endocarditis due to viridans streptococci, enterococci and staphylococci. Characteristics of infective endocarditis; Etiologic diagnosis; Antimicrobial treatment for the condition; Methods of monitoring the adequacy of antibiotic therapy.

  • Current aspects of infective endocarditis. Mansi, Ishak A.; Carden, Donna // Patient Care for the Nurse Practitioner;Jun2004, Vol. 7 Issue 6, p3 

    The article provides information on infective endocarditis (IE). The mean age of patients with native valve endocarditis increased from 35 years in the preantibiotic era to a current mean age of 54 years. The pathogens of IE have changed because of surges in cases due to Staphylococcus aureus...

  • Non-HACEK Gram-Negative Bacillus Endocarditis. Morpeth, Susan; Murdoch, David; Cabell, Christopher H.; Karchmer, Adolf W.; Pappas, Paul; Levine, Donald; Nacinovich, Francisco; TattevinR, Pierre; Fernández-Hidalgo, Núria; Dickerman, Stuart; Bouza, Emilio; del Río, Ana; Lejko-Zupanc, Tatjana; de Oliveira Ramos, Auristela; Iarussi, Diana; Klein, John; Chirouze, Catherine; Bedimo, Roger; Corey, G. Ralph; Fowler Jr., Vance G. // Annals of Internal Medicine;12/18/2007, Vol. 147 Issue 12, p829 

    Background: Infective endocarditis caused by non-HACEK (species other than Haemophilus species, Actinobacillus actinomycetemcomitans, Cardiobacterium hominis, Eikenella corrodens, or Kingella species) gram-negative bacilli is rare, is poorly characterized, and is commonly considered to be...

  • Successful Treatment of Vancomycin-Resistant Enterococcus Endocarditis with Oral Linezolid. Babcock, Hilary M.; Starlin, Richard; Little, Russell; Stanley, Sam; Ritchie, David J.; Christiansen, Erin // Clinical Infectious Diseases;5/1/2001, Vol. 32 Issue 9, p1373 

    Discusses the effectiveness of the antimicrobial agent linezolid in treating vancomycin-resistant Enterococcus faecium endocarditis. Information on linezolid; Characteristics of the patient; Results of treatment using chloramphenicol and quinupristin/dalfopristin.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics